John H Knab, MD Pain Medicine - Interventional Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1602 Physicians Dr, Ste 103, Wilmington, NC 28401 Phone: 910-442-1200 Fax: 910-442-1296 |
Francis S Pecoraro, MD Pain Medicine - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 2716 Ashton Dr, Wilmington, NC 28412 Phone: 910-332-3800 Fax: 910-251-0421 |
Sunil K Arora, MD Pain Medicine - Interventional Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1602 Physicians Dr, Suite 103, Wilmington, NC 28401 Phone: 910-442-1200 Fax: 910-442-1296 |
Breanna Jordan Brousseau, NP Pain Medicine - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1202 Medical Center Dr, Wilmington, NC 28401 Phone: 910-341-3459 Fax: 910-343-0438 |
Matthew Douglas Mclaren, MD Pain Medicine - Interventional Pain Medicine Medicare: Medicare Enrolled Practice Location: 5710 Oleander Dr Ste 201, Wilmington, NC 28403 Phone: 833-365-7246 |
Dr. Jeremy Jay Hoff, D.O. Pain Medicine - Interventional Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 2716 Ashton Dr, Wilmington, NC 28412 Phone: 910-332-3800 Fax: 910-251-0421 |
Naomi Namrota Jackson, PA-C Pain Medicine - Pain Medicine Medicare: Medicare Enrolled Practice Location: 2909 Market St, Wilmington, NC 28403 Phone: 910-795-2118 |
News Archive
The human body contains a unique protein that has the unusual property of destroying itself after a few hours of existence - it must therefore be continually recreated and is no stable protein.
United Spinal Association and Independence Care System (ICS), are co-sponsoring the first annual conference to improve the lives, health, and well-being of women with disabilities.
One of two dozen major trauma centers named to be a part of the Department of Defense-funded Major Extremity Trauma Research Consortium (METRC), Saint Louis University will work to improve treatment for wounded service members and civilians. The partnership aims to conduct research to improve the care of major orthopaedic injuries sustained on the battlefield.
Exelixis, Inc. today announced final results from BRIM7, an ongoing phase 1b clinical trial conducted by Roche and Genentech, Exelixis' collaborator and a member of the Roche Group, of the BRAF inhibitor (BRAFi) vemurafenib in combination with the MEK inhibitor cobimetinib in patients with locally advanced/unresectable or metastatic melanoma carrying a BRAFV600 mutation.
As part of Patient Safety Awareness Week, the American College of Radiology (ACR) reminds patients that everyone should understand radiology benefits and risks before they or a loved one receives an X-ray, computed tomography (CT) scan or other medical imaging exam.
› Verified 8 days ago